Browsing Tag
Infectious disease
18 posts
Pfizer and BioNTech secure FDA approval for LP.8.1-adapted COMIRNATY vaccine for high-risk groups
Pfizer and BioNTech's LP.8.1-adapted COVID-19 vaccine gets FDA approval for high-risk groups. Find out what this means for the 2025–2026 rollout season.
August 28, 2025
Measles (rubella): understanding the cause, symptoms, transmission, and why vaccination is essential for prevention
Learn how measles (rubella) spreads, what causes its rash and fever, and why vaccination is crucial to prevent severe complications and long-term health risks.
July 19, 2025
Bavarian Nordic to acquire Vivotif and Vaxchora travel vaccines from Emergent BioSolutions
Bavarian Nordic A/S will acquire two oral vaccines from Emergent BioSolutions for a total consideration of up to…
February 17, 2023
Visby Medical adds $35m to Series E round for PCR diagnostic technology
Visby Medical, an American medical diagnostic company, has raised an additional $35 million for its PCR diagnostic technology…
July 2, 2022
Cipla to acquire 21% stake in medical test kits provider Achira Labs
Cipla Limited has agreed to acquire a stake of 21.05% in Achira Labs, a provider of point of…
June 17, 2022
Model Medicines, Sanford Burnham Prebys forge AI-driven drug discovery partnership
AI drug discovery software company Model Medicines has signed a multi-target collaboration agreement with California-based Sanford Burnham Prebys…
March 23, 2021
Thermo Fisher Scientific to acquire Mesa Biotech for $500m to expand point-of-care diagnostics
Thermo Fisher Scientific, a global leader in laboratory and diagnostics solutions, has finalized an agreement to acquire Mesa…
January 20, 2021
Gilead Sciences announces Veklury EU approval for COVID-19 treatment
Veklury EU approval : Gilead Sciences said that Veklury (remdesivir) has been given conditional marketing authorization from the…
July 6, 2020
FDA grants EUA for Gilead’s investigational COVID-19 drug remdesivir
Remdesivir EUA status : The US has officially pushed the use of remdesivir for treating the novel coronavirus…
May 4, 2020
Eiger BioPharmaceuticals doses first patients with Lambda in COVID-19 trial
Eiger BioPharmaceuticals said that it has dosed the first patients in a phase 2 trial of its hepatitis…
May 1, 2020